• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRAINLAB AG CRANIAL NAVIGATION SOFTWARE (VERSION 3.1); IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRAINLAB AG CRANIAL NAVIGATION SOFTWARE (VERSION 3.1); IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC Back to Search Results
Model Number 22216A
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Device Handling Problem (3265)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/05/2016
Event Type  No Answer Provided  
Manufacturer Narrative
Despite according to the surgeon: a post-operative mri scan confirmed that the trajectory path of the biopsies was correct as intended, and that the unsuccessful biopsy samples were taken in the correct path, but 20mm before the intended target (corresponding to the "tool tip offset" used); there were no negative clinical effects to this patient due to this issue / biopsy resection at this surgery; there was no (direct or increased) risk to harm a critical brain structure (e.G.Blood vessels or important brain tissue) due to the biopsy at location different than desired; there was also no negative effect to the patient due to anesthesia prolong (at this surgery of ca.20min prolong); there are no other remedial actions necessary, done or planned for this patient due to this issue other than additional biopsy apply at same surgery to retrieve desired samples; the surgery was completed successfully as intended with desired samples retrieved at same surgery.A risk to the patient's health could not be excluded for these specific circumstances, since biopsy samples were taken in a different location in the brain than intended (although within the correct path), with the brainlab device involved.According to the results of the brainlab investigation and the information provided by the hospital, it can be concluded that the root cause for the location of biopsy different than intended is a misinterpretation of the information displayed by the navigation: the tool tip offset selected and displayed was navigated to the target, instead of the needle tip.There is no indication of a malfunction or systematic error of the brainlab device, the brainlab device (navigation) works as specified; corresponding measures for the brainlab device (navigation) to minimize this anticipated risk as low as reasonably practicable are already in place.Brainlab intends to re-iterate to this customer: the display functions available in the navigation for the "tool tip offset" function, and to correspondingly always verify the current setting for the used instrument; that in general a stopper should be used with a biopsy needle.Additionally, the use of a stopper might also aid to detect an insertion potentially not yet deep enough for the intended target; despite not being the root cause for this issue here: brainlab has not validated the marker spheres nor the biopsy cannula used by this hospital in conjunction with the brainlab navigation system, and therefore brainlab is not in a position to determine the accuracy, compatibility or safety of these other marker spheres nor this other biopsy cannula.
 
Event Description
A cranial surgery for a biopsy of a cyst (from tumor resection) located ca.40mm deep in the brain (pre-central region) with a size of ca.50mm, has been performed with the aid of the virtual display of the brainlab navigation.A pre-operative mri was acquired before the surgery, to use with navigation.A trajectory for the biopsy was pre-operatively planned on that mri.During the procedure the surgeon: performed the initial patient registration on the pre-op mri to match the virtual display of the navigation to the current patient anatomy; verified the accuracy of the registration on the patient's skin to be acceptable for use; located the target with the navigated pointer using the "tool tip offset" function, with an offset of 20mm added, and marked the target location on the patient's skin; draped the patient, re-checked accuracy, created a burr hole, set the trajectory path and placed a navigated biopsy needle with the aid of brainlab navigation and the preplanned target point; took 3 biopsy samples with 3 needle insertions, and determined from the consistency of the samples that they were not from the intended target (cyst), without needing to send them to pathology first; removed the "tool tip offset" in the navigation, and took 2 further biopsy samples with 2 needle insertions with still the same trajectory path set at the same surgery.These 2 biopsies were successful and contained the expected fluid samples from the desired target (cyst).These samples were sent to pathology.According to the surgeon: a post-operative mri scan confirmed that the trajectory path of the biopsies was correct as intended, and that the unsuccessful biopsy samples were taken in the correct path, but 20mm before the intended target (corresponding to the "tool tip offset" used); there were no negative clinical effects to this patient due to this issue / biopsy resection at this surgery; there was no (direct or increased) risk to harm a critical brain structure (e.G.Blood vessels or important brain tissue) due to the biopsy at location different than desired; there was also no negative effect to the patient due to anesthesia prolong (at this surgery of ca.20min prolong); there are no other remedial actions necessary, done or planned for this patient due to this issue other than additional biopsy apply at same surgery to retrieve desired samples; the surgery was completed successfully as intended with desired samples retrieved at same surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRANIAL NAVIGATION SOFTWARE (VERSION 3.1)
Type of Device
IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC
Manufacturer (Section D)
BRAINLAB AG
kapellenstrasse 12
feldkirchen, 85622
GM  85622
Manufacturer (Section G)
BRAINLAB AG
kapellenstrasse 12
feldkirchen, 85622
GM   85622
Manufacturer Contact
markus hofmann
kapellenstrasse 12
feldkirchen, 85622
GM   85622
89 9915680
MDR Report Key5614854
MDR Text Key43885705
Report Number8043933-2016-00014
Device Sequence Number1
Product Code HAW
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K092467
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician Assistant
Type of Report Initial
Report Date 04/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/28/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number22216A
Device Catalogue Number71201A
Device Lot NumberSW V. 3.1
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/05/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/17/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-